Michael K. Wendt
Professor and Head | Basic Medical Sciences |
OFFICE
201 S. University St. Hansen Life Sciences Research Building Rm 114 and 625 Harrison St. Lynn Hall Rm 2174 AREAS OF RESEARCH Molecular Biology Cancer Biology Models of Metastasis Genetics Pharmacology |
LAB
201 S. University St. Hansen Life Sciences Research Building Rm 111 EDUCATION B.S., Biology, St. Norbert College, DePere, WI Ph.D., Molecular Genetics, Medical College of Wisconsin, Milwaukee, WI |
BIOGRAPHY
Dr. Wendt graduated with a bachelor's degree from St. Norbert College in 2002. After completing his graduate studies at the Medical College of Wisconsin in 2008, Dr. Wendt became an American Cancer Society fellow with Dr. William Schiemann at the University of Colorado Cancer Center. In 2010 Dr. Wendt moved with the Schiemann lab to Case Western Reserve University where he received a K99/R00 transition award from the NCI. Dr. Wendt joined the faculty of Purdue University as an Assistant Professor in 2014. In 2016 Dr. Wendt was awarded the the Research Scholar Grant for the American Cancer Society. In 2019 Dr. Wendt was promoted to Associate Professor with tenure. From 2020-2024 Dr. Wendt was a standing member of the tumor evolution, heterogeneity, and metastasis (TEHM) study section for the NIH. In 2022 Dr. Wendt become a Showalter faculty scholar in life sciences at Purdue University. In 2023 Dr. Wendt was recruited to the University of Iowa where he was the Arlene Holden Professor of Breast Cancer Research, director of the translational breast cancer research program, and co-leader of the Experimental Therapeutics program within the Holden Comprehensive Cancer Center. In 2025 Dr. Wendt was recruited back to Purdue as Head of the Basic Medical Sciences Department.
Dr. Wendt graduated with a bachelor's degree from St. Norbert College in 2002. After completing his graduate studies at the Medical College of Wisconsin in 2008, Dr. Wendt became an American Cancer Society fellow with Dr. William Schiemann at the University of Colorado Cancer Center. In 2010 Dr. Wendt moved with the Schiemann lab to Case Western Reserve University where he received a K99/R00 transition award from the NCI. Dr. Wendt joined the faculty of Purdue University as an Assistant Professor in 2014. In 2016 Dr. Wendt was awarded the the Research Scholar Grant for the American Cancer Society. In 2019 Dr. Wendt was promoted to Associate Professor with tenure. From 2020-2024 Dr. Wendt was a standing member of the tumor evolution, heterogeneity, and metastasis (TEHM) study section for the NIH. In 2022 Dr. Wendt become a Showalter faculty scholar in life sciences at Purdue University. In 2023 Dr. Wendt was recruited to the University of Iowa where he was the Arlene Holden Professor of Breast Cancer Research, director of the translational breast cancer research program, and co-leader of the Experimental Therapeutics program within the Holden Comprehensive Cancer Center. In 2025 Dr. Wendt was recruited back to Purdue as Head of the Basic Medical Sciences Department.